Tech Company Financing Transactions
Treeline Biosciences Funding Round
On 10/17/2022, Treeline Biosciences secured $261.3 million in funding from Access Industries, Arch Venture Partners and OrbiMed.
Transaction Overview
Company Name
Announced On
10/17/2022
Transaction Type
Venture Equity
Amount
$261,300,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
677 Washington Boulevard 525
Stamford, CT 06901
USA
Stamford, CT 06901
USA
Phone
Undisclosed
Website
Email Address
Overview
We aspire to build transformative precision medicines for patients with cancer and other serious conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Bilenker
Chief Financial Officer
Michelle Buturla
Chief Scientific Officer
Jeffrey Engelman
Browse more venture capital transactions:
Prev: 10/17/2022: Fastned venture capital transaction
Next: 10/17/2022: Maplerad venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs